JP2009513165A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513165A5
JP2009513165A5 JP2006516183A JP2006516183A JP2009513165A5 JP 2009513165 A5 JP2009513165 A5 JP 2009513165A5 JP 2006516183 A JP2006516183 A JP 2006516183A JP 2006516183 A JP2006516183 A JP 2006516183A JP 2009513165 A5 JP2009513165 A5 JP 2009513165A5
Authority
JP
Japan
Prior art keywords
plga
weight
plasticized
temperature
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006516183A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513165A (ja
Filing date
Publication date
Priority claimed from IT001302A external-priority patent/ITMI20031302A1/it
Application filed filed Critical
Publication of JP2009513165A publication Critical patent/JP2009513165A/ja
Publication of JP2009513165A5 publication Critical patent/JP2009513165A5/ja
Pending legal-status Critical Current

Links

JP2006516183A 2003-06-26 2004-06-24 Plgaマトリックス中に分散された熱不安定性活性成分を含有する皮下インプラントを製造するための可塑剤としてのエタノールの使用 Pending JP2009513165A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001302A ITMI20031302A1 (it) 2003-06-26 2003-06-26 Uso di etanolo come plasticizzante per preparare impianti sottocutanei contenenti principi attivi termolabili dispersi in una matrice di plga.
PCT/EP2004/051226 WO2005000277A1 (en) 2003-06-26 2004-06-24 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix

Publications (2)

Publication Number Publication Date
JP2009513165A JP2009513165A (ja) 2009-04-02
JP2009513165A5 true JP2009513165A5 (cg-RX-API-DMAC7.html) 2011-05-06

Family

ID=30131301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006516183A Pending JP2009513165A (ja) 2003-06-26 2004-06-24 Plgaマトリックス中に分散された熱不安定性活性成分を含有する皮下インプラントを製造するための可塑剤としてのエタノールの使用

Country Status (17)

Country Link
US (1) US8206621B2 (cg-RX-API-DMAC7.html)
EP (1) EP1638534B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009513165A (cg-RX-API-DMAC7.html)
KR (1) KR101143771B1 (cg-RX-API-DMAC7.html)
CN (1) CN100509060C (cg-RX-API-DMAC7.html)
AT (1) ATE398447T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004251456B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0411759A (cg-RX-API-DMAC7.html)
CA (1) CA2530117C (cg-RX-API-DMAC7.html)
CY (1) CY1108346T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004014496D1 (cg-RX-API-DMAC7.html)
ES (1) ES2308195T3 (cg-RX-API-DMAC7.html)
IT (1) ITMI20031302A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05013697A (cg-RX-API-DMAC7.html)
PL (1) PL1638534T3 (cg-RX-API-DMAC7.html)
PT (1) PT1638534E (cg-RX-API-DMAC7.html)
WO (1) WO2005000277A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
US8221778B2 (en) 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8329203B2 (en) 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
JP5405825B2 (ja) * 2005-07-18 2014-02-05 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 薬剤含有インプラント及びその使用方法
ITMI20061539A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
ATE539102T1 (de) 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc Kugelförmige polymer-partikel
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
US9498431B2 (en) * 2008-12-10 2016-11-22 Jianjian Xu Controlled releasing composition
WO2012003210A1 (en) * 2010-06-30 2012-01-05 Surmodics Pharmaceuticals, Inc. Implant processing methods for thermally labile and other bioactive agents and implants prepared from same
GB201314312D0 (en) * 2013-08-09 2013-09-25 Regentec Ltd Composition and delivery system
CN103623415B (zh) * 2013-12-04 2015-03-25 北京诺康达医药科技有限公司 一种用于生物多肽制剂的plga与乙醇的复合物
EP3177319A1 (en) * 2014-08-04 2017-06-14 Janssen Sciences Ireland UC Compacted solid dosage form
GB201702475D0 (en) * 2017-02-15 2017-03-29 Locate Therapeutics Ltd Tissue scaffold and scaffold composition
EP3459527B1 (en) * 2017-09-20 2022-11-23 Tillotts Pharma Ag Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0549629A (ja) * 1991-08-23 1993-03-02 Konica Corp 医用放射線画像読影装置
US5520923A (en) * 1994-09-19 1996-05-28 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
NZ533434A (en) 2001-11-14 2006-11-30 Alza Corp Thixotropic gel composition for injectable deposition

Similar Documents

Publication Publication Date Title
Janib et al. A quantitative recipe for engineering protein polymer nanoparticles
CN110897161A (zh) 一种高荷载姜黄素的大豆多肽基纳米颗粒及其pH驱动制备方法与应用
MY166979A (en) Dry storage stabilizing compositions for biological materials
CA2530117A1 (en) Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
Koenigs et al. Tuning cross-link density in a physical hydrogel by supramolecular self-sorting
CN1705469A (zh) 聚合物辅助的有益剂递送体系
Bobrin et al. Temperature-Directed Self-Assembly of Multifunctional Polymeric Tadpoles
JP2012532860A (ja) 架橋されたタンパク質ナノ結晶、架橋されたタンパク質ナノ凝集体およびそれらの調製方法
ATE95984T1 (de) Verfahren zur herstellung von einem mit schneller freisetzung stabilisierten aspartambestandteil fuer kaugummis.
DE59906894D1 (de) Rieselfähige granulate
DE60138131D1 (de) Verfahren zur herstellung von methionin-haltigen granulaten
CN104031210B (zh) 季铵盐表面改性的单分散聚苯乙烯微球乳液的制备方法
JP6783960B2 (ja) 熱抑制処理澱粉及び/又は穀粉の再湿潤化
KR20190020583A (ko) 향이 오래 지속되는 방향제
CN110313618A (zh) 一种维生素d2微胶囊的制备方法
KR101757890B1 (ko) 기능성 물질의 방출 제어를 위한 고분자-다공성 무기담체 복합체의 제조 방법
CN114288408B (zh) 双佐剂自载体原位纳米疫苗及其制备方法
Song et al. Enhanced Antigen Capture via Cholinephosphate‐Mediated Cell Membrane Interactions to Improve In Situ Tumor Vaccines
JP5509494B2 (ja) 粉体の製造方法、粉体、吸着装置
Martin et al. Modulating protein interaction on a molecular and microstructural level for texture control in protein based gels
CN105073633B (zh) 固体产氧组合物
US12227760B2 (en) Wet granulated cell culture medium and preparation method therefor
JP2008001671A (ja) 化粧品組成物
CN104447949A (zh) 多肽和药物组合物及其制备方法
KR101340506B1 (ko) 누에생실샘 미세분말을 포함하는 베이비 파우더